Hepatitis C inhibitor tri-peptides

1 2 233 23 4 Compounds of formula (I): wherein Ris hydroxyl or sulfonamide derivative; Ris t-butyl or -CH-C(CH)or -CH-cyclopentyl; Ris t-butyl or cyclohexyl and Ris cyclobutyl, cyclopentyl or cyclohexyl; or a pharmaceutically acceptable salt thereof, are described as useful as inhibitor of the HCV N...

Full description

Saved in:
Bibliographic Details
Main Authors Llinas-Brunet, Montse, Bailey, Murray D, Ghiro, Elise
Format Patent
LanguageEnglish
Published 15.08.2006
Online AccessGet full text

Cover

More Information
Summary:1 2 233 23 4 Compounds of formula (I): wherein Ris hydroxyl or sulfonamide derivative; Ris t-butyl or -CH-C(CH)or -CH-cyclopentyl; Ris t-butyl or cyclohexyl and Ris cyclobutyl, cyclopentyl or cyclohexyl; or a pharmaceutically acceptable salt thereof, are described as useful as inhibitor of the HCV NS3 protease.